Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
00:04:01 EDT Sat 20 Apr 2024
Enter Symbol
or Name
USA
CA



Q:OPK - OPKO HEALTH INC - http://www.opko.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
OPK - Q0.11.11·1.251.61.232,665.53,0414,9941.20  1.2415  1.202.24  0.851619:57:25Mar 2815 min RT 2¢

Recent Trades - Last 10 of 4994
Time ETExPriceChangeVolume
19:57:25Q1.22-0.013
19:57:07Q1.21-0.021
19:46:27Q1.22-0.0150
19:45:38Q1.21-0.02100
19:44:27Q1.21-0.0250
19:41:59Q1.22-0.01250
19:39:31Q1.22-0.01500
19:39:20Q1.21-0.021
19:25:42Q1.22-0.0150
19:19:42Q1.21-0.021

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-28 08:00U:OPKNews ReleaseLabcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business
2024-03-20 08:00U:OPKNews ReleaseEntera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome
2024-03-05 08:52U:OPKNews ReleaseAIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
2024-02-28 09:31U:OPKNews ReleaseNextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st
2024-02-27 16:05U:OPKNews ReleaseOPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results
2024-02-22 16:05U:OPKNews ReleaseOPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024
2024-02-05 08:09U:OPKNews ReleaseNextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China
2024-01-09 16:05U:OPKNews ReleaseOPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser ¢ € ™s Option to Purchase Additional Notes
2024-01-08 08:00U:OPKNews ReleaseOPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2024-01-04 23:31U:OPKNews ReleaseOPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
2024-01-03 17:06U:OPKNews ReleaseOPKO Health Announces Private Offering of Convertible Senior Notes Due 2029
2023-11-28 07:00U:OPKNews ReleaseBioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing
2023-11-07 06:45U:OPKNews ReleaseBioReference ‚ ® Signs On as the First Laboratory to Use MSK-ACCESS ‚ ® Powered with SOPHiA DDM ¢ „ ¢
2023-11-06 16:05U:OPKNews ReleaseOPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results
2023-11-02 10:00U:OPKNews ReleaseNew Clinical Data on OPKO Health ¢ € ™s RAYALDEE ‚ ® (ER Calcifediol) Presented at Kidney Week 2023
2023-10-31 08:00U:OPKNews ReleaseOPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023
2023-10-25 16:25U:OPKNews ReleaseOPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023
2023-10-12 14:45U:OPKNews ReleaseNextPlat's Florida E-Commerce Development Program to Launch the Online Sales of OPKO Healthcare Products in China on Alibaba's Tmall Global
2023-09-28 16:08U:OPKNews ReleaseModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats